Jay Venkatesan - 16 Dec 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
President and Chief Executive Officer and Director, Director
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for Jay. R. Venkatesan
Issuer symbol
ELTX
Transactions as of
16 Dec 2021
Net transactions value
+$105,951
Form type
4
Filing time
20 Dec 2021, 17:44:28 UTC
Previous filing
21 Sep 2021
Next filing
22 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Purchase $70,993 +27,883 +2.1% $2.55 1,344,744 16 Dec 2021 Direct F1
transaction ELTX Common Stock Purchase $34,958 +13,742 +1% $2.54 1,358,486 17 Dec 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.55 inclusive.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.55 inclusive.

Remarks:

President and Chief Executive Officer and Director